{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:57:47Z","timestamp":1791496667712,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R891"],"award-info":[{"award-number":["PNURSP2025R891"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["ORF-2025\\u20131185"],"award-info":[{"award-number":["ORF-2025\\u20131185"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.toxrep.2025.102184","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:19:35Z","timestamp":1765423175000},"page":"102184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Synthesis, characterization, and anticancer evaluation of N-Heterocyclic entities: ADME profiling and In Silico predictions"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9462-2039","authenticated-orcid":false,"given":"Zakariae","family":"Abbaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oussama","family":"Khibech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcseyin","family":"Karci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"D\u00fcndar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lknur","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson Agerico","family":"Dino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naifa","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Touzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Alghibiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2025.102184_bib1","doi-asserted-by":"crossref","first-page":"28783","DOI":"10.1021\/jacs.4c07785","article-title":"Blood\u2013brain barrier-penetrative fluorescent anticancer agents triggering paraptosis and ferroptosis for glioblastoma therapy","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.toxrep.2025.102184_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac357","article-title":"A merged molecular representation deep learning method for blood\u2013brain barrier permeability prediction","volume":"23","author":"Tang","year":"2022","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.toxrep.2025.102184_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10133","article-title":"Molecular docking and in vitro anticancer studies of silver (I)-N-heterocyclic carbene complexes","volume":"8","author":"Akko\u00e7","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.toxrep.2025.102184_bib4","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/med.22039","article-title":"A promising future of metal-N-heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents","volume":"44","author":"Zhao","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.toxrep.2025.102184_bib5","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/acsmedchemlett.5c00096","article-title":"Gold (I) N-Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents","volume":"16","author":"Schlegel","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.toxrep.2025.102184_bib6","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.3390\/ijms26104620","article-title":"In Silico Approach to Design of New Multi-Targeted Inhibitors Based on Quinoline Ring with Potential Anticancer Properties","volume":"26","author":"Czy\u017cnikowska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2025.102184_bib7","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1158\/1538-7445.AM2024-5779","article-title":"Enhancing selectivity and overcoming tissue-specific toxicity in drug discovery: A novel BET inhibitor with targeted delivery for prostate cancer treatment","volume":"84","author":"Tang","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.toxrep.2025.102184_bib8","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1158\/1538-7445.AM2023-5744","article-title":"Decreasing toxicity of immunocytokines by transient and selective inhibition of their intracellular signaling activation","volume":"83","author":"Rotta","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.toxrep.2025.102184_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/ph16020299","article-title":"Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.toxrep.2025.102184_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejmech.2017.05.064","article-title":"Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs","volume":"137","author":"El-Gohary","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib11","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2174\/0929867327666200525161359","article-title":"Immunoconjugates for cancer targeting: a review of antibody-drug conjugates and antibody-functionalized nanoparticles","volume":"28","author":"Petrilli","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib12","doi-asserted-by":"crossref","first-page":"16131","DOI":"10.1039\/D1RA01093J","article-title":"Gold nanoparticles conjugated with anti-CD133 monoclonal antibody and 5-fluorouracil chemotherapeutic agent as nanocarriers for cancer cell targeting","volume":"11","author":"Mohd-Zahid","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.toxrep.2025.102184_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11596-020-2200-6","article-title":"Strategies for precise engineering and conjugation of antibody targeted-nanoparticles for cancer therapy","volume":"40","author":"Guo","year":"2020","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.toxrep.2025.102184_bib14","series-title":"in: Semin. Cancer Biol","first-page":"556","article-title":"Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers","author":"Chen","year":"2022"},{"key":"10.1016\/j.toxrep.2025.102184_bib15","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3390\/cancers13133210","article-title":"Epigenetic deregulation of apoptosis in cancers","volume":"13","author":"Ozyerli-Goknar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.toxrep.2025.102184_bib16","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.3390\/cancers13205059","article-title":"Progress on Ras\/MAPK signaling research and targeting in blood and solid cancers","volume":"13","author":"Dillon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.toxrep.2025.102184_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/biomedicines11030654","article-title":"Epigenetic regulators of DNA cytosine modification: promising targets for Cancer Therapy","volume":"11","author":"Jung","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.toxrep.2025.102184_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/psp4.12904","article-title":"Gene expression databases for physiologically based pharmacokinetic modeling of humans and animal species","volume":"12","author":"Cordes","year":"2023","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"key":"10.1016\/j.toxrep.2025.102184_bib19","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxrep.2025.102184_bib20","article-title":"Computational Insights into Pharmacokinetic Profiling of Amygdalin: An In-Silico Study","volume":"44","author":"Sachdeva","year":"2023","journal-title":"J. Adv. Zool."},{"key":"10.1016\/j.toxrep.2025.102184_bib21","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1039\/C9TB02700A","article-title":"Amphetamine decorated cationic lipid nanoparticles cross the blood\u2013brain barrier: Therapeutic promise for combating glioblastoma","volume":"8","author":"Saha","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.toxrep.2025.102184_bib22","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1021\/jacs.2c13701","article-title":"Homotypic membrane-enhanced blood\u2013brain barrier crossing and glioblastoma targeting for precise surgical resection and photothermal therapy","volume":"145","author":"Zhang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.toxrep.2025.102184_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10623","article-title":"Micro Trojan horses: Engineering extracellular vesicles crossing biological barriers for drug delivery","volume":"9","author":"Zeng","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.toxrep.2025.102184_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.crtox.2024.100159","article-title":"Alzheimer\u2019s disease: In silico study of rosemary diterpenes activities","volume":"6","author":"Abbaoui","year":"2024","journal-title":"Curr. Res. Toxicol."},{"key":"10.1016\/j.toxrep.2025.102184_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260853","article-title":"Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study","volume":"16","author":"Bitew","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.toxrep.2025.102184_bib26","doi-asserted-by":"crossref","first-page":"1145974","DOI":"10.3389\/fchem.2023.1145974","article-title":"Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches","volume":"11","author":"Ahmad","year":"2023","journal-title":"Front. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/molecules26020375","article-title":"Identification of DNA methyltransferase-1 inhibitor for breast cancer therapy through computational fragment-based drug design","volume":"26","author":"Alkaff","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.toxrep.2025.102184_bib28","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11030-024-10907-8","article-title":"Benzimidazole scaffold as a potent anticancer agent with different mechanisms of action (2016\u20132023)","volume":"29","author":"Hagar","year":"2025","journal-title":"Mol. Divers"},{"key":"10.1016\/j.toxrep.2025.102184_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/00958972.2025.2477596","article-title":"Novel fluorinated benzimidazole-based N-heterocyclic carbene precursor and its silver (I) and selenium adducts: synthesis, spectral characterization, DFT\/TD-DFT, QTAIM, and in silico ADME investigations","volume":"78","author":"Serin","year":"2025","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/00958972.2022.2164191","article-title":"Novel benzimidazolium salts and their silver (I)-N-heterocyclic carbene complexes: Synthesis, characterization and their biological properties","volume":"76","author":"Belhi","year":"2023","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2024.121992","article-title":"Sythesis, characterisation, anticancer and antimicrobial activity of Ag-N-heterocyclic carbene complexes containing benzimidazole derivatives","volume":"565","author":"Karci","year":"2024","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.toxrep.2025.102184_bib32","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1158\/1538-7445.AM2024-7208","article-title":"Targeting histone demethylase KDM6B to overcome cisplatin resistance in testicular germ cell tumors","volume":"84","author":"Singh","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.toxrep.2025.102184_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1039\/D2MO00220E","article-title":"Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches","volume":"19","author":"Yue","year":"2023","journal-title":"Mol. Omi."},{"key":"10.1016\/j.toxrep.2025.102184_bib34","doi-asserted-by":"crossref","first-page":"16545","DOI":"10.3390\/ijms242216545","article-title":"Molecular characteristics of cisplatin-induced ototoxicity and therapeutic interventions","volume":"24","author":"Tan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2025.102184_bib35","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.3390\/ijms23137241","article-title":"Can cisplatin therapy be improved? Pathways that can be targeted","volume":"23","author":"Ali","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2025.102184_bib36","article-title":"Cisplatin-based combination therapy for cancer","author":"Bhat","year":"2023","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.toxrep.2025.102184_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac544.3046","article-title":"Single cell sequencing unveils endothelial alterations after cisplatin treatment","volume":"43","author":"Pan","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.toxrep.2025.102184_bib38","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.3390\/cancers16132478","article-title":"Emerging therapeutic strategies to overcome drug resistance in cancer cells","volume":"16","author":"Garg","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.toxrep.2025.102184_bib39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/pharmaceutics16070928","article-title":"Use of drug sensitisers to improve therapeutic index in cancer","volume":"16","author":"Chen","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.toxrep.2025.102184_bib40","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.3390\/app13095561","article-title":"Recent advances in bioconjugated transition metal complexes for cancer therapy","volume":"13","author":"Bortolamiol","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.toxrep.2025.102184_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200597","article-title":"Metal complexes for cancer sonodynamic therapy","volume":"24","author":"Mandal","year":"2023","journal-title":"ChemBioChem"},{"key":"10.1016\/j.toxrep.2025.102184_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14756366.2020.1837124","article-title":"Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea\/thiourea moieties with potential cytotoxicity and CDK inhibitory activities","volume":"36","author":"Shawky","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib43","first-page":"3195957","article-title":"Ligand-based and docking-based virtual screening of MDM2 inhibitors as potent anticancer agents","volume":"2021","author":"Li","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.toxrep.2025.102184_bib44","doi-asserted-by":"crossref","first-page":"14808","DOI":"10.1039\/D3RA01316B","article-title":"In silico studies of a novel scaffold of benzoxazole derivatives as anticancer agents by 3D-QSAR, molecular docking and molecular dynamics simulations","volume":"13","author":"Jiang","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.toxrep.2025.102184_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40203-025-00445-y","article-title":"In silico and in vitro evaluation of N-heterocyclic derivatives as antimicrobials: ADMET analysis, SAR, and molecular docking","volume":"13","author":"Abbaoui","year":"2025","journal-title":"Silico Pharm."},{"key":"10.1016\/j.toxrep.2025.102184_bib46","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1080\/07391102.2020.1778533","article-title":"Pharmacore maping based on docking, ADME\/toxicity, virtual screening on 3, 5-dimethyl-1, 3, 4-hexanetriol and dodecanoic acid derivates for anticancer inhibitors","volume":"39","author":"Prakash","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.toxrep.2025.102184_bib47","article-title":"Synthesis, analysis adme-tox parameters and anti-cancer activity of n-(5-r-benzylthiazole-2-yl)-2-morpholin-4-yl-2-thioxoacetamides","volume":"73","author":"Drapak","year":"2024","journal-title":"Proc. Shevchenko Sci. Soc. Med. Sci."},{"key":"10.1016\/j.toxrep.2025.102184_bib48","first-page":"859","article-title":"Exploring phenoxazinone synthase activities: experimental and theoretical analyses of symmetrical azine ligands","volume":"12","author":"Meziane","year":"2024","journal-title":"Phys. Chem. Res."},{"key":"10.1016\/j.toxrep.2025.102184_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.17509\/ajse.v5i2.88662","article-title":"Combined pyrazole and Cu (II), Co (II) Metals: an excellent catalyst for catecholase, tyrosinase, phenoxazinone synthase, and laccase for oxygen activation","volume":"5","author":"Abbaoui","year":"2025","journal-title":"ASEAN J. Sci. Eng."},{"key":"10.1016\/j.toxrep.2025.102184_bib50","unstructured":"Z. Ridal, Z. Abbaoui, H. Elmsellem, A. Aouniti, E.B. Yousfi, M.El Kodadi, C. Belkhiri, F. Souna, R. Touzani, A.A. Elhenawy, Multifaceted Applications of Pyrazole-Based Tetradentate Ligand Coordinated with Transition Metals (Fe, Zn, Co, Cu): Synthesis, Characterization, Catalysis, Antimicrobial Activity, ADMET, and Molecular Docking Insights, ASEAN J. Sci. Eng. 6 (n.d.) 149\u2013172."},{"key":"10.1016\/j.toxrep.2025.102184_bib51","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1007\/s00044-011-9804-0","article-title":"Synthesis and enzyme inhibitory activities of some new pyrazole-based heterocyclic compounds","volume":"21","author":"Harit","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.toxrep.2025.102184_bib52","article-title":"Evaluation of anticancer activity of silver nanoparticles on the A549 human lung carcinoma cell lines through alamar blue assay","volume":"9","author":"Sharma","year":"2019","journal-title":"BioProtoc."},{"key":"10.1016\/j.toxrep.2025.102184_bib53","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib54","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.toxrep.2025.102184_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.toxrep.2025.102184_bib56","unstructured":"A. Kinsner-Ovaskainen, P.M.D.P. Prieto, I. Mangelsdorf, C. Bieler, T. Cole, S. Hoffmann, Acute oral toxicity: Variability, reliability, relevance and interspecies comparison of rodent LD50 data from literature surveyed for the ACuteTox project, (n.d.)."},{"key":"10.1016\/j.toxrep.2025.102184_bib57","first-page":"383","article-title":"Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line","volume":"Vitr. 50","author":"Malm","year":"2018","journal-title":"Toxicol"},{"key":"10.1016\/j.toxrep.2025.102184_bib58","unstructured":"A. PRICE, Utilisation de mod\u00e8les in vitro de barri\u00e8re h\u00e9mato-enc\u00e9phalique dans les phases pr\u00e9coces du d\u00e9veloppement de m\u00e9dicaments, (n.d.)."},{"key":"10.1016\/j.toxrep.2025.102184_bib59","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/molecules28020838","article-title":"Imidazole: synthesis, functionalization and physicochemical properties of a privileged structure in medicinal chemistry","volume":"28","author":"Tolomeu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.toxrep.2025.102184_bib60","doi-asserted-by":"crossref","unstructured":"A. Rahimi, O. Khibech, A. Benabbou, M. Merzouki, M. Bouhrim, M. Al-zharani, F.A. Nasr, A.A. Qurtam, S. Abadi, A. Challioui, M. Mimouni, M. Elbekay, ADMET-Guided Docking and GROMACS Molecular Dynamics of Ziziphus lotus Phytochemicals Uncover Mutation-Agnostic Allosteric Stabilisers of the KRAS Switch-I \/ II Groove, (2025) 1\u201320.","DOI":"10.3390\/ph18081110"},{"key":"10.1016\/j.toxrep.2025.102184_bib61","first-page":"1548","article-title":"Phytochemical profile, antioxidant and antimicrobial activities of aerial parts of Stachys germanica subsp. cordigera Briq: In","volume":"13","author":"Ouakil","year":"2025","journal-title":"Vitr. Eval. Silico Mol. Docking Study"},{"key":"10.1016\/j.toxrep.2025.102184_bib62","first-page":"10","article-title":"ASEAN Journal of Science and Engineering Valorization of Imidazolium-Based Salts as Next- Generation Antimicrobials: Integrated Biological Evaluation","author":"Merimi","year":"2025","journal-title":"ADMET Mol. Docking Dyn. Stud."},{"key":"10.1016\/j.toxrep.2025.102184_bib63","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/s41467-018-05954-3","article-title":"Modeling the impact of drug interactions on therapeutic selectivity","volume":"9","author":"Weinstein","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxrep.2025.102184_bib64","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.52202\/068431-0895","article-title":"Reinforced genetic algorithm for structure-based drug design","volume":"35","author":"Fu","year":"2022","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.toxrep.2025.102184_bib65","doi-asserted-by":"crossref","unstructured":"M. Teng, N. Usman, C.A. Frederick, volume 16 Number 6 1988 Nucleic Acids Research, 16 (1988) 2671\u20132690.","DOI":"10.1093\/nar\/16.6.2671"},{"key":"10.1016\/j.toxrep.2025.102184_bib66","doi-asserted-by":"crossref","first-page":"93194","DOI":"10.1039\/C5RA16605E","article-title":"A novel benzimidazole derivative binds to the DNA minor groove and induces apoptosis in leukemic cells","volume":"5","author":"Hegde","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.toxrep.2025.102184_bib67","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bmc.2019.01.011","article-title":"Synthesis and biological evaluation of pyrazole linked benzothiazole-\u03b2-naphthol derivatives as topoisomerase I inhibitors with DNA binding ability","volume":"27","author":"Nagaraju","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib68","doi-asserted-by":"crossref","unstructured":"\u3008www.bio-protocol.org\/e3128\u3009, 9 (2019) 1\u201313. https:\/\/doi.org\/10.21769\/BioProtoc.3128.","DOI":"10.21769\/BioProtoc.3128"},{"key":"10.1016\/j.toxrep.2025.102184_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","article-title":"Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations","volume":"52","author":"Kalyanaraman","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.toxrep.2025.102184_bib70","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbabio.2008.03.029","article-title":"Targeting lipophilic cations to mitochondria","volume":"1777","author":"Murphy","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA)Bioenerg."},{"key":"10.1016\/j.toxrep.2025.102184_bib71","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cmdc.201100306","article-title":"Revisiting the rule of five on the basis of pharmacokinetic data from rat","volume":"6","author":"Ridder","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.toxrep.2025.102184_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.toxrep.2025.102184_bib73","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.toxrep.2025.102184_bib74","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s43440-024-00675-5","article-title":"LY354740, an agonist of glutamatergic metabotropic receptor mGlu2\/3 increases the cytochrome P450 2D (CYP2D) activity in the frontal cortical area of rat brain","volume":"76","author":"Bromek","year":"2024","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.toxrep.2025.102184_bib75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/026119298901700205","article-title":"Cytotoxicity evaluation of the first ten MEIC chemicals: acute lethal toxicity in man predicted by cytotoxicity in five cellular assays and by oral LD50 tests in rodents","volume":"17","author":"Ekwall","year":"1989","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.toxrep.2025.102184_bib76","first-page":"163","article-title":"Pharmacokinetic properties and In Silico ADME modeling in drug discovery","volume":"9","author":"M. Honorio","year":"2013","journal-title":"Med. Chem. (Los. Angel )."},{"key":"10.1016\/j.toxrep.2025.102184_bib77","doi-asserted-by":"crossref","unstructured":"Y. Fang, R.M. Eglen, Three-Dimensional Cell Cultures in Drug Discovery and Development, (2017). https:\/\/doi.org\/10.1177\/1087057117696795.","DOI":"10.1177\/2472555217696795"}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025003038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025003038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:15:51Z","timestamp":1786533351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025003038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":77,"alternative-id":["S2214750025003038"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102184","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization, and anticancer evaluation of N-Heterocyclic entities: ADME profiling and In Silico predictions","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.102184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102184"}}